ANNX

Annexon, Inc. Common Stock
Data: 2026-09-04
Quick Stats
Sep 04, 2026

56.1

AI Score

BUY

0.5

Volume Ratio

TBA

Next Earnings

12

+ve Days (30d)

18

-ve Days (30d)

ANNX Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

ANNX Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

ANNX Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ANNX Daily Out of Money Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ANNX Daily In the Money Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ANNX Most Active Options by Volume(near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track
ANNX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ANNX Stock Summary

Last updated Sep 04, 2026

ANNX is currently trading at $4.87, positioned below its 200-day moving average of $5.39, suggesting bearish momentum. The stock has a 52-week range of $2.1 to $7.18.

Technical Analysis: The 50-day moving average stands at $5.38, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.75, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.052, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ANNX at 56.1/100 with a BUY recommendation.

ANNX (Annexon, Inc. Common Stock) Indicators

Last updated Sep 04, 2026

Indicator Value
RSI(14) 41.75
CMF (20) 0.052
ROC (10) -3.945
ADX (14) 12.196
Indicator Value
MACD (12,26,9) -0.122
AROONOSC (14) -78.571
WILLAMS %R (14) -87.273
MFI (14) 44.249

Annexon, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

ANNX Moving Averages Analysis

ANNX (Annexon, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Sep 04, 2026

Days MA
10 4.99
20 5.13
30 5.16
50 5.38
100 5.43
200 5.39

ANNX Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 917.6 million
Earnings/Share ($) -1.11
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -1.0503
EPS Estimate Next Year ($) -1.0824
WallStreet Target Price ($) 15.29
Most Recent Quarter

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.